Recent Finacing
Recent Raise
Gennao Bio develops targeted nucleic acid therapies using a GMAB platform of cell‑penetrating antibodies for non‑viral, repeatable delivery of diverse nucleic payloads, focused on oncology and skeletal muscle diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Gennao Bio.
